Teleflex (NYSE:TFX) today posted third-quarter results that beat the earnings consensus on Wall Street but missed revenue estimates. The Wayne, Pennsylvania–based maker of critical care and surgical products reported profits of $101.9 million, or $2.16 per share, on sales of $686.8 million for the three months ended Sept. 27. The results represented a bottom-line slide […]
Teleflex
Teleflex completes $170M Standard Bariatrics acquisition
Teleflex (NYSE:TFX) announced today that it completed its acquisition of Standard Bariatrics and its powered stapling technology. Wayne, Pennsylvania–based Teleflex announced its acquisition of Cincinnati-based Standard Bariatrics last month. The definitive agreement included a $170 million price for the bariatric surgery technology developer at closing. Teleflex could pay up to an additional $130 million upon […]
Teleflex partners on VR training for its UroLift 2 system
Teleflex (NYSE:TFX) announced today that it entered into a new agreement with FundamentalVR over integration for medical simulation. Wayne, Pennsylvania-based Teleflex’s agreement with FunamentalVR, a leader in virtual reality (VR) integration for medical simulation, will provide Teleflex with a VR training platform to accelerate the effective use of its UroLift 2 system. UroLift 2, a […]
Teleflex to acquire Standard Bariatrics and its powered stapling technology
Teleflex today announced it has entered into a definitive agreement to acquire Standard Bariatrics and its powered stapling technology for bariatric surgery. Teleflex will acquire the Cincinnati, Ohio-based company for an upfront cash payment of $170 million at closing with additional consideration of up to $130 million that will be payable upon the achievement of […]
Teleflex lowers guidance on mixed bag Q2 results
Teleflex (NYSE:TFX) posted second-quarter results today that missed the revenue consensus on Wall Street and cut its outlook for the rest of the year. Shares in TFX were down 10.40% to $238.80 apiece in mid-morning trading. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was up 1.1%. The […]
Teleflex enrolls first patient in vascular closure device study
Teleflex (NYSE:TFX) announced today that it enrolled the first patient in a clinical study of its Manta vascular closure device. In the study, Wayne, Pennsylvania-based Teleflex intends to demonstrate the safety of Manta ultrasound-guided closure without dependence on the pre-procedural depth locator measurements. According to a news release, the study will enroll up to 150 […]
Teleflex’s UroLift cleared in China to treat BPH
Teleflex (NYSE:TFX) today announced it received National Medical Products Administration (NMPA) approval for its UroLift system in China to treat benign prostatic hyperplasia (BPH). Wayne, Pennsylvania-based Teleflex designed UroLift as a minimally invasive treatment option for lower urinary tract symptoms due to BPH and is indicated in the U.S. for the treatment of an enlarged prostate […]
Teleflex wins Health Canada nod for Manta vascular closure device
Teleflex (NYSE:TFX) today announced its Manta vascular closure device received Health Canada approval. Wayne, Pennsylvania-based Teleflex designed the Manta biomechanics vascular closure device for large bore femoral arterial access site closure. “Our team has been working diligently to obtain this approval and were confident that Health Canada would recognize the benefits of the Manta device,” […]
Teleflex stock down despite Street-beating Q1
Teleflex (NYSE:TFX) shares slided today, even as the company reported first-quarter results that came in ahead of the consensus forecast. The Wayne, Pennsylvanis–based critical care and surgical tech company posted profits of $77.1 million, or $1.63 per share, on sales of $641.7 million for the three months ended March 27, 2022, for a 3% bottom-line […]
Teleflex launches UroLift in Japan
Teleflex (NYSE:TFX) announced today that it launched its UroLift system for treating benign prostatic hyperplasia (BPH) in Japan. Wayne, Pennsylvania–based Teleflex made the UroLift system for BPH or enlarged prostate available for purchase immediately, having recently received reimbursements approval from the Central Social Insurance Medical Council of Japan (Chuikyo). The company designed UroLift as a […]
Teleflex up on Street-beating Q4
Teleflex (NYSE: TFX) today reported fourth-quarter results that beat the consensus forecast on Wall Street, predicting continued growth amid a headwind from last year’s respiratory business divestiture. The Wayne, Pennsylvania–based critical care and surgical tech company earned $128.1 million, or $2.70 per share, off sales of $761.9 million for the quarter ended Dec. 31, 2021, […]